Sorry, my opinion what not meant to be a correction of yours. I too don't buy the valuation at a billion dollars. Not sure how they came to that since it is unproven. I just think if the drug does do anything, it will be huge. Not sure on the French or other big pharm companies.
To my understanding, the bought the patent for the chemical synthesis from the french. Then did the testing on their own and had the article in September 2012
They are not a billion dollar company, they were valued at a billion if the techonogy proves out.
They need the funding to move it forward. The story here is whether or not they get the funding at the 0.02 mark they are looking at. We will wait and see.
News 
Market Data 
Discover 
